title: Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML.
authors.forename: Soheil
authors.initials: S
authors.lastname: Meshinchi
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Arceci
authors.forename: Jean E
authors.initials: JE
authors.lastname: Sanders
authors.forename: Franklin O
authors.initials: FO
authors.lastname: Smith
authors.forename: William B
authors.initials: WB
authors.lastname: Woods
authors.forename: Jerald P
authors.initials: JP
authors.lastname: Radich
authors.forename: Todd A
authors.initials: TA
authors.lastname: Alonzo
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D051941:fms-Like Tyrosine Kinase 3 / Q000378:metabolism*
chemical_list: C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3